The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

In this week’s edition of The Prototype, we look at quantum computing for image recognition, a gene therapy using a patient’s ...